Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2017

01-07-2017 | Case report

Ropinirole

Psychosis: case report

Published in: Reactions Weekly | Issue 1/2017

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
…
Literature
Sarangmat N, et al. Deep Brain Stimulation in a case with Parkinsonism and SCA2 mutation: Case report highlighting challenges and outcome. Movement Disorders 32 (Suppl. S2): Jun 2017. Available from: URL: http://​doi.​org/​10.​1002/​mds.​27087 [abstract] - United Kingdom
Metadata
Title
Ropinirole
Psychosis: case report
Publication date
01-07-2017
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-32604-7

Other articles of this Issue 1/2017

Reactions Weekly 1/2017 Go to the issue

Case report

Pembrolizumab

Case report

Bendamustine/rituximab/granulocyte colony stimulating factors

Case report

Erlotinib/trastuzumab

Case report

Alimemazine/desloratadine/fexofenadine/loratadine

Case report

Metronidazole

Case report

Indometacin